Verition Fund Management
HAE icon

Verition Fund Management’s Haemonetics HAE Stock Holding History

Verition Fund Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.91M Buy
+105,508
New +$6.78M 0.04% 453
2026
Q1 		– Sell
-11,300
Closed -$906K – 2820
2025
Q4 		$906K Sell
11,300
-12,916
-53% -$868K ﹤0.01% 2230
2025
Q3 		$1.18M Sell
24,216
-7,583
-24% -$469K ﹤0.01% 2400
2025
Q2 		$2.37M Buy
+31,799
New +$2.11M 0.01% 1793
2025
Q1 		– Sell
-4,381
Closed -$342K – 3475
2024
Q4 		$342K Buy
4,381
+1,411
+48% +$113K ﹤0.01% 2703
2024
Q3 		$239K Sell
2,970
-3,415
-53% -$276K ﹤0.01% 2775
2024
Q2 		$528K Buy
6,385
+4,005
+168% +$352K ﹤0.01% 2024
2024
Q1 		$203K Sell
2,380
-290
-11% -$22.8K ﹤0.01% 2494
2023
Q4 		$228K Buy
2,670
+290
+12% +$25.1K ﹤0.01% 1952
2023
Q3 		$213K Buy
2,380
+26
+1% +$2.32K ﹤0.01% 1943
2023
Q2 		$200K Sell
2,354
-1,426
-38% -$121K ﹤0.01% 1860
2023
Q1 		$313K Buy
+3,780
New +$306K ﹤0.01% 1496
2021
Q2 		– Sell
-7,436
Closed -$825K – 1992
2021
Q1 		$825K Buy
+7,436
New +$920K 0.01% 662
2020
Q1 		– Sell
-8,238
Closed -$947K – 792
2019
Q4 		$947K Buy
+8,238
New +$997K 0.02% 468
2018
Q4 		– Sell
-3,917
Closed -$449K – 994
2018
Q3 		$449K Sell
3,917
-12,198
-76% -$1.26M 0.02% 878
2018
Q2 		$1.45M Buy
+16,115
New +$1.36M 0.09% 278
2017
Q4 		– Sell
-5,738
Closed -$257K – 998
2017
Q3 		$257K Sell
5,738
-5,702
-50% -$237K 0.02% 948
2017
Q2 		$452K Buy
+11,440
New +$470K 0.04% 478
2017
Q1 		– Sell
-5,712
Closed -$230K – 1284
2016
Q4 		$230K Buy
+5,712
New +$215K 0.02% 971

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verition Fund Management's HAE Position: Q2 2026 in Review

Verition Fund Management opened a new position in Haemonetics (HAE) in Q2 2026: 105,508 shares worth $7.91M. The stake represents 0.04% of the portfolio and ranks #453 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in HAE as recently as Q4 2025.

Verition Fund Management first reported a position in HAE in Q4 2016 and has held it in 19 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Verition Fund Management held 105,508 shares of Haemonetics worth $7.91M as of Q2 2026.
  • Haemonetics was a new Verition Fund Management position in Q2 2026.
  • Haemonetics made up 0.04% of Verition Fund Management's portfolio in Q2 2026, its #453 holding.
  • Verition Fund Management first reported a position in Haemonetics in Q4 2016 and has held it in 19 quarters since.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.